GE Capital funds diagnostics company; FDA clears device for treatment of pulmonary embolism;

@FierceMedDev: Atossa board adopts 'poison pill' remedy in wake of FDA crackdown. More | Follow @FierceMedDev

@VarunSaxena2: After months of silence, FDA returns to name and shame strategy on pediatric trial compliance. Story | Follow @VarunSaxena2

@MichaelGFierce: Smallest, fastest nanomotor moves drugs and releases them on demand. Article | Follow @MichaelGFierce

@EmilyWFierce: Doctors in Italy designed a mini dialysis machine that could save the lives of infants. More | Follow @EmilyWFierce

> GE Capital led a $32 million funding round for Mason, OH, based diagnostic company Assurex Health. Story

> BTG International received 510(k) clearance for its EkoSonic Endovascular System for the treatment of pulmonary embolism. Release

> The FDA's recently released final guidance on transferring the oversight of clinical trials to another institutional review board contains only small changes from the draft version. Story

Biotech News

@FierceBiotech: This week's EuroBiotech Report: AZ and Europe's 'innovation malaise,' €30M Irish life sci fund, and more. Report | Follow @FierceBiotech

@JohnCFierce: So, something has changed at the CHMP on conditional approvals, and I don't know what it is. Can anyone fill in the blanks here? | Follow @JohnCFierce

@DamianFierce: PTC convinces CHMP to change its mind on conditional approval of the DMD drug ataluren. Story | Follow @DamianFierce

@EmilyMFierce: Beware! Crackpot science: Article. File under: Why I don't watch TV news. | Follow @EmilyMFierce

> Lilly, Boehringer pick up EU nod for FDA-spurned diabetes treatment. More

> The EU's not impressed with Novartis' 'breakthrough' cardio drug, either. Story

> Former CDER official joins Greenleaf Health, biosimilars experience in tow. Chutes & Ladders

Pharma News

@FiercePharma: Takeda now 5 for 6 in winning Actos cases, but that loss was a stunner. Article | Follow @FiercePharma

@TracyStaton: Some AstraZeneca investors are balking at the board's Pfizer snub. Others are practically high-fiving Chairman Johannson. Story | Follow @TracyStaton

@EricPFierce: So you thought you would get through the holidays without more Pfizer/AstraZeneca news? Not a chance. More | Follow @EricPFierce

@CarlyHFierce: Ok, this Rolaids-sponsored spelling bee just passed vaccine car seats for my favorite thing today. Article | Follow @CarlyHFierce

> Roche gets thumbs up for CLL use of Gazyvaro in EU. News

> California goes after Purdue, Endo, J&J, Actavis and Teva over opioids. More

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.